SCHEMBL14086000

SCHEMBL14086000

CNC(=O)[C@H]1CCCC1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.50
GRM4 Q14833 1/20 0.42
OPRM1 P35372 1/20 0.35
PSEN1 P49768 3/20 0.34
PSEN2 P49810 3/20 0.34
APH1B Q8WW43 3/20 0.34
NCSTN Q92542 3/20 0.34
APH1A Q96BI3 3/20 0.34
PSENEN Q9NZ42 3/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CNR2 P34972 3/20 0.33
CHRNB2 P17787 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32
CNR1 P21554 2/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
ITGB2 P05107 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14087092 1.00 EPHX1 (0.50) EPHX1GRM4OPRM1PSEN1PSEN2
SCHEMBL17860102 1.00 EPHX1 (0.50) EPHX1GRM4OPRM1PSEN1PSEN2
SCHEMBL13538931 0.95 EPHX1 (0.56) EPHX1GRM4OPRM1CNR2CNR1
SCHEMBL18464017 0.82 EPHX1 (0.38) EPHX1GRM4PSEN1PSEN2APH1B
SCHEMBL5909473 0.80 GRM4 (0.56) EPHX1GRM4CHRNB2CHRNA7CHRNA4
SCHEMBL12439047 0.78 EPHX1 (0.47) EPHX1OPRM1MEN1KMT2ACHRNB2
SCHEMBL14085998 0.78 EPHX1 (0.47) EPHX1OPRM1MEN1KMT2ACHRNB2
SCHEMBL22826694 0.78 EPHX1 (0.47) EPHX1OPRM1MEN1KMT2ACHRNB2
SCHEMBL30463526 0.77 EPHX1 (0.56) EPHX1OPRM1CNR2CNR1CA1
SCHEMBL8198307 0.77 EPHX1 (0.50) EPHX1GRM4OPRM1PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221083-A1 Heterobicyclic metalloprotease inhibitors HOCHGURTEL MATTHIAS 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221083-A1 Heterobicyclic metalloprotease inhibitors MMP13, MMP3, TIMP3 EPHX1 1476/4885GRM4 4226/4885OPRM1 1413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.